MENU
TARS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Tarsus Pharmaceuticals (TARS) Earnings Date & Reports

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care... Show more

A.I. Advisor
published Earnings

TARS is expected to report earnings to fall 71.40% to -8 cents per share on March 16

Tarsus Pharmaceuticals TARS Stock Earnings Reports
Q4'25
Est.
$-0.09
Q3'25
Beat
by $0.05
Q2'25
Missed
by $0.10
Q1'25
Beat
by $0.15
Q4'24
Beat
by $0.17
The last earnings report on November 04 showed earnings per share of -30 cents, beating the estimate of -34 cents. With 354.55K shares outstanding, the current market capitalization sits at 3.07B.
View a ticker or compare two or three
TARS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TARS showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
15440 Laguna Canyon Road
Phone
+1 949 409-9820
Employees
244
Web
https://www.tarsusrx.com